Albert Bourla DVM Ph.D.

Albert Bourla DVM Ph.D.

Chairman & CEO at Pfizer
Company Tenure: 4 years
Education:
Aristotle University of Thessaloniki (Ph.D.) Aristotle University of Thessaloniki (D.V.M.)
Biography:

Albert Bourla has been affiliated Pfizer for more than 30 years, currently serving as the Chief Executive Officer. His other affiliations include the International Federation of Pharmaceutical Manufacturers & Associations, the United States Council for International Business, the Council on Foreign Relations, The Business Council and The Business Roundtable. He holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University, a Doctor of Philosophy in Biotechnology of Reproduction from Aristotle University of Thessaloniki, a Doctor of Veterinary Medicine, Honorary Doctorate from American College of Greece, an Honorary Doctorate from the University of Patras, an Honorary Doctorate from Touro University, an Honorary Doctorate from The Technion-Israel Institute of Technology, an Honorary Doctorate from Aristotle University, and Honorary Doctorate from Babson College.

Profile Details

Total Political Contributions More information

Republican Support
Democratic Support
$114,900 $44,100

Affiliated Companies

Pfizer

Pfizer

Key Statements

“But however, within this beauty, America is also having problems with systematic racism more than other places in the world, and inability of different groups to integrate with others. And I see diversity and inclusion—I saw it from the first day—as two different faces of the same coin. Diversity is about bringing people from different backgrounds inside Pfizer and to try to create, recreate, a diverse society within the organization. Inclusiveness is having the conditions that they feel welcomed, that they feel that they belong, that they don't feel that they are outsiders into that.”<br />

Source Link

“… we have articulated that we want to be the leaders in our industry in ESG and I think that all three letters of the ESG are relevant to us.”

Source Link

“What we are experiencing, though, and I'm going to the second, it is a societal crisis right now. I'm not speaking about the misinformation that is spread through the social media because misinformation is wrong information but can be innocent. You don't know that you lie. You say what you think is true. That can create some damage because some people can believe you and you confuse people. But in any case, it's happening, always was happening. We are speaking about organized disinformation. This is senders that, on purpose, they spread malicious information, false information that they know is false because they have an agenda to destabilize society, to make a political move, to make an easy back and to basically discredit institutions. And now the enemy, because we went into the COVID and became a very big deal, the enemy is science. Doesn't matter if it is a Pfizer science or if it is Tony Fauci science or if it is CDC science or if it is FDA science. They are all a conspiracy that they are trying together to harm people.”

Source Link

“And equity, make sure you think about when you do your pricing is easy. To have one price for all is more difficult to have different prices for different tiers of customers because we'll be criticized. But that's the right thing to do. Equity is not giving everyone the same. Equity is giving more to those that they need more that's equity, right? So that's what we felt.”

Source Link